In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.
Yajko, D M
In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin. [electronic resource] - Antimicrobial agents and chemotherapy Dec 1990 - 2442-4 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0066-4804
10.1128/AAC.34.12.2442 doi
Acquired Immunodeficiency Syndrome--complications
Anti-Infective Agents--pharmacology
Ciprofloxacin--pharmacology
Drug Synergism
Ethambutol--pharmacology
Fluoroquinolones
Microbial Sensitivity Tests
Mycobacterium avium Complex--drug effects
Mycobacterium avium-intracellulare Infection--etiology
Rifampin--pharmacology
In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin. [electronic resource] - Antimicrobial agents and chemotherapy Dec 1990 - 2442-4 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0066-4804
10.1128/AAC.34.12.2442 doi
Acquired Immunodeficiency Syndrome--complications
Anti-Infective Agents--pharmacology
Ciprofloxacin--pharmacology
Drug Synergism
Ethambutol--pharmacology
Fluoroquinolones
Microbial Sensitivity Tests
Mycobacterium avium Complex--drug effects
Mycobacterium avium-intracellulare Infection--etiology
Rifampin--pharmacology